alexa Neeloo Singh | CSIR Central Drug Research Institute
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Neeloo Singh

Biochemistry Division,  CSIR Central Drug Research Institute, India
Biography

Dr. Neeloo Singh is currently working as a Principal Scientist in the Biochemistry Division at Central Drug Research Institute. Her educational qualification is M.Sc., Ph.D. She did her Post-Doctoral research in the Northern Ireland Regional Tissue Typing Laboratory at Belfast City Hospital, Northern Ireland, U.K. She has published many articles on her research work.

Research Interest

Dr. Neeloo Singh's research interest includes Molecular Biology of Leishmania Parasites and Molecular Parasitology of Malaria and Leishmania 

 

Publications

Synthesis of Nanoparticles Using Euphorbia prostrata Extract Reveals a Shift from Apoptosis to G0/G1 Arrest in Leishmania donovani

Abdul Abduz Zahir, Indira Singh Chauhan, Asokan Bagavan, Chinnaperumal Kamaraj, Gandhi Elango, Jai Shankar, Nidhi Arjaria, Mohana Roopan, Abdul Abdul Rahuman*, Neeloo Singh*

Research Article: J Nanomed Nanotechnol 2014, 5:213

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords